A review of omalizumab for the management of severe asthma

Overview of attention for article published in Drug Design, Development and Therapy, July 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 8,060 followers.

RT @alergologos: Una revisión del omalizumab para el manejo del asma grave (abstract en inglés, vía @asthma_papers): https://t.co/ogWHg5MiMR

Una revisión del omalizumab para el manejo del asma grave (abstract en inglés, vía @asthma_papers): https://t.co/ogWHg5MiMR

RT @asthma_papers: A review of omalizumab for the management of severe asthma. https://t.co/m4LDXYmehc

A review of omalizumab for the management of severe asthma. https://t.co/m4LDXYmehc

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.